Invesco India Pharma And Healthcare Fund holds 15 instruments (87.01% equity), led by Max Healthcare Institute Limited (9.58%), Sun Pharmaceutical Industries Limited (8.99%) and Sai Life Sciences Limited (8.63%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of Invesco India Pharma And Healthcare Fund, managed by Invesco Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 15 instruments with an equity allocation of 87.01%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
Invesco India Pharma And Healthcare Fund's top 10 holdings account for 75.44% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 87.01% of net assets, spread across 1 sector in total.
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
| # | Holding | Sector | % to NAV |
|---|---|---|---|
| 1 | Triparty Repotreps | — | 20.56% |
| 2 | Max Healthcare Institute Limited | Healthcare | 9.58% |
| 3 | Sun Pharmaceutical Industries Limited | Healthcare | 8.99% |
| 4 | Sai Life Sciences Limited | Healthcare | 8.63% |
| 5 | Apollo Hospitals Enterprise Limited | Healthcare | 8.03% |
| 6 | MANIPAL HEALTH ENTERPRISES L | Healthcare | 7.98% |
| 7 | Divi's Laboratories Limited | Healthcare | 7.85% |
| 8 | Global Health Limited | Healthcare | 7% |
| 9 | Dr. Agarwal's Health Care Limited | Healthcare | 6.32% |
| 10 | CORONA Remedies Limited | Healthcare | 6.13% |
| 11 | Torrent Pharmaceuticals Limited | Healthcare | 4.93% |
| 12 | Glenmark Pharmaceuticals Limited | Healthcare | 4.86% |
| 13 | Krishna Institute of Medical Sciences Limited | Healthcare | 4.72% |
| 14 | Aster DM Healthcare Limited | Healthcare | 1.99% |
| 15 | Net Receivables / (Payables)other | — | -7.57% |
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Invesco Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.